Home > Boards > US OTC > Biotechs > NorthWest Biotherapeutics Inc. (NWBO)

Estimates are estimates for a good reason. They

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Horseb4CarT Member Profile
 
Followed By 6
Posts 258
Boards Moderated 0
Alias Born 09/01/17
160x600 placeholder
Quarterly Report (10-q) Edgar (US Regulatory) - 8/10/2020 4:44:16 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/7/2020 5:27:35 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/26/2020 5:07:03 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 6/24/2020 6:02:25 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/8/2020 5:02:02 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/4/2020 5:12:40 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 5/29/2020 5:28:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/27/2020 5:15:15 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/20/2020 5:06:06 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 5/12/2020 4:12:38 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/23/2020 5:10:20 PM
Cannabis? CBD? That's Old News, A New Sector Bull Run Has Begun InvestorsHub NewsWire - 4/16/2020 8:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 4/9/2020 5:28:45 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/1/2020 4:41:56 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 3/27/2020 2:47:39 PM
Annual Report (10-k) Edgar (US Regulatory) - 3/16/2020 5:01:48 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 2/24/2020 5:07:15 PM
PURA ALERT - MACD Cross Pushing $0.039 50 Day MA With $0.35 Analyst TGT Recommendation InvestorsHub NewsWire - 2/10/2020 12:50:46 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/15/2020 4:54:03 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/3/2020 5:04:36 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/13/2019 4:25:29 PM
Citation Growth Corp. (OTCQX: CGOTF) Weathering the Cannabis Downturn InvestorsHub NewsWire - 12/9/2019 7:23:11 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/12/2019 5:19:23 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 11/1/2019 6:00:56 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 10/28/2019 5:12:01 PM
Horseb4CarT   Saturday, 07/04/20 08:25:52 PM
Re: anders2211 post# 293595
Post # of 300115 
Estimates are estimates for a good reason. They are educated projections at a current time of what is going to happen in the future and how long each step and what dependencies and impacts other tasks and events are going to come into play. Some tasks and events are internal and you can have more control or influence on, and others are external, etc..

Project plans sometimes change based on what actually is happening.

I’m sure many people here have had direct experience in projects, including home projects.

S__t happens, might be a familiar refrain.

Ok, some are better at planning and estimating than others and some projects are more complex.

A first of a kind trial where even the FDA is learning along the way, and involving a tiny company that was an easy target for unfriendly interests, and not flush with cash, and we hold this company to our strict interpretation of their steps and milestones?

It’s quite an accomplishment to get across the finish line at all, and no doubt shareholders have been slighted along the way and strung along some to keep things going. How many of us would still be here if we thought the trial would be 10 years+ long. NWBO probably didn’t think it would be that long either when the trial was launched.

Anyway it is what it is, and what it has been. The success or failure of this trial is imminent and we all believe the shareholder outcome will be binary, whether a number of days or weeks longer. Success should be very rewarding and failure wipes this investment out.

Each one of us have to make our best decisions for our individual situation. I decided a number of years ago that I’d stick it out to the end, and celebrate or accept the losses unless it was clear the science wouldn’t be good enough.

GLTA

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist